Literature DB >> 28340996

Diabetes for Cardiologists: Practical Issues in Diagnosis and Management.

G B John Mancini1, Alice Y Cheng2, Kim Connelly3, David Fitchett3, Ronald Goldenberg4, Shaun G Goodman3, Lawrence A Leiter5, Eva Lonn6, Breay Paty7, Paul Poirier8, James Stone9, David Thompson7, Jean-François Yale10.   

Abstract

Diabetes mellitus (DM), a chronic metabolic disease characterized by hyperglycemia, is a profound cardiovascular (CV) risk factor. It compounds the effects of all other risk factors, leads to premature micro- and macrovascular disease, facilitates development of heart failure, worsens the clinical course of all CV diseases, and shortens life expectancy. Established DM, unrecognized DM, and dysglycemia that may progress to DM are all commonly present at the time of presentation of overt CV disease. Thus, CV specialists and trainees frequently treat patients with dysglycemia. The traditional and proven role of cardiologists in reducing the risk of macrovascular events in this population is through aggressive lipid and blood pressure treatment. However, a more proactive role in the detection and management of DM is likely to become increasingly important as the prevalence continues to increase and therapies continue to improve. The latter include antihyperglycemic therapies with proven cardiovascular safety profiles and CV event reduction properties not yet fully elucidated and not necessarily related to glycemic control. Accordingly, the purpose of this article is to (1) expand the interest of cardiologists in earlier stages of the natural history of DM, when prevention or early detection might help achieve greatest benefit; (2) highlight principles of optimal glycemic management, with an emphasis on add-on choices showing promising reduction of CV events and lacking CV adverse effects; and (3) encourage cardiologists to become proactive partners in the multidisciplinary care needed to ensure optimal lifelong vascular health in patients with, or who are at risk of, DM.
Copyright © 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28340996     DOI: 10.1016/j.cjca.2016.07.512

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  9 in total

1.  Expression of transient receptor potential vanilloid genes and proteins in diabetic rat heart.

Authors:  Xiaoli Jia; Tao Yu; Chao Xiao; Deqiao Sheng; Mengcheng Yang; Quanyi Cheng; Jing Wu; Ting Lian; Yun Zhao; Shizhong Zhang
Journal:  Mol Biol Rep       Date:  2021-02-01       Impact factor: 2.316

2.  Cardiometabolic medicine: time to recognize a new clinical specialty?

Authors:  Andrew J Krentz; Stephan Jacob
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

3.  Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis.

Authors:  Naghmeh Mirhosseini; Hassanali Vatanparast; Mohsen Mazidi; Samantha M Kimball
Journal:  J Endocr Soc       Date:  2018-05-25

4.  Liraglutide Effect on Weight, Glycated Hemoglobin, and Blood Pressure: A Single-Center Experience in the Eastern Province of Saudi Arabia.

Authors:  Duaa M Alsafwani; Hind N Alotaibi; Jawaher A Alzaid; Amal Alghamdi; Huda M Almakhaita
Journal:  Cureus       Date:  2022-03-27

5.  Jiangtang Tongmai Prescription Reduced Diabetic Lung Injury Through SnoN and TGF-β1/Smads Signaling Pathway.

Authors:  Nian Ding; Chenghong Zheng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

6.  Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions.

Authors:  Veysel Oktay; İlknur Calpar Çıralı; Ümit Yaşar Sinan; Ahmet Yıldız; Murat Kazım Ersanlı
Journal:  Anatol J Cardiol       Date:  2017-10-31       Impact factor: 1.596

7.  Metformin Modulates High Glucose-Incubated Human Umbilical Vein Endothelial Cells Proliferation and Apoptosis Through AMPK/CREB/BDNF Pathway.

Authors:  Xiqiong Han; Bilei Wang; Yuning Sun; Jia Huang; Xin Wang; Wenqi Ma; Yi Zhu; Rongfeng Xu; Hong Jin; Naifeng Liu
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

Review 8.  Curcumin, Cardiometabolic Health and Dementia.

Authors:  Yoona Kim; Peter Clifton
Journal:  Int J Environ Res Public Health       Date:  2018-09-24       Impact factor: 3.390

9.  Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis.

Authors:  Lu Yu; Yu Zhai; Shanmei Shen
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.